SCHEMBL3397202

SCHEMBL3397202

CC(C)CCCCCCCCCCCCCCCOC(=O)CCC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 2/20 0.46
PHF8 Q9UPP1 2/20 0.46
KDM2A Q9Y2K7 2/20 0.46
KDM4A O75164 1/20 0.46
HTR2C P28335 1/20 0.44
RARB P10826 1/20 0.42
ALDH1A1 P00352 1/20 0.41
NAAA Q02083 1/20 0.40
DGKA P23743 1/20 0.40
NPC1 O15118 1/20 0.39
ADRA2A P08913 1/20 0.38
ADRA1A P35348 1/20 0.38
MAPT P10636 1/20 0.37
BLM P54132 1/20 0.37
KDM6B O15054 1/20 0.37
KDM5C P41229 1/20 0.37
EGLN1 Q9GZT9 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37
PAM P19021 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL237975 1.00 KDM4C (0.46) KDM4CPHF8KDM2AKDM4AHTR2C
SCHEMBL848602 1.00 KDM4C (0.46) KDM4CPHF8KDM2AKDM4AHTR2C
SCHEMBL26686943 1.00 KDM4C (0.46) KDM4CPHF8KDM2AKDM4AHTR2C
SCHEMBL30115059 1.00 KDM4C (0.46) KDM4CPHF8KDM2AKDM4AHTR2C
SCHEMBL2853053 1.00 KDM4C (0.46) KDM4CPHF8KDM2AKDM4AHTR2C
SCHEMBL27216277 1.00 KDM4C (0.46) KDM4CPHF8KDM2AKDM4AHTR2C
Succinic Acid SCHEMBL28092056 1.00 KDM4C (0.46) KDM4CPHF8KDM2AKDM4AHTR2C
SCHEMBL28221894 0.98 KDM4C (0.45) KDM4CPHF8KDM2AKDM4AHTR2C
SCHEMBL27496280 0.98 KDM4C (0.45) KDM4CPHF8KDM2AKDM4AHTR2C
SCHEMBL27216289 0.93 KDM4C (0.41) KDM4CPHF8KDM2AKDM4AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010061242-A1 COMPACT POWDER FREE OF BINDER IN FREE FORM L'OREAL (FR) 2010-06-03 WO claimed
US-20230025897-A1 TONER PARTICLES HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2023-01-26 US disclosed
WO-2021112964-A1 TONER PARTICLES HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2021-06-10 WO disclosed
WO-2010061242-A1 COMPACT POWDER FREE OF BINDER IN FREE FORM L'OREAL (FR) 2010-06-03 WO disclosed
US-20070275022-A1 Cosmetic Hair Preparation LION CORPORATION (JP) 2007-11-29 US disclosed
CN-1307865-A Nanometer emulsion containing amphiphilic lipoid and polyglycol ester OREAL (FR) 2001-08-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275022-A1 Cosmetic Hair Preparation CUTA, H1-10, PUF60 KDM4C 2611/4885PHF8 412/4885KDM2A 3227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.